Decreasing Stress in Diabetes (De-Stress)
Primary Purpose
Stress, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mindfulness Based Stress Reduction
Stress Management Education
Sponsored by
About this trial
This is an interventional treatment trial for Stress focused on measuring Stress, Psychological, Mindfulness, Meditation, Mind-Body Therapies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Eligibility Criteria
Inclusion Criteria:
- Men and Women
- Age 18 years or older
- Diagnosed with diabetes for at least one year
- Hemoglobin A1c ≥ 7.5% within 10 weeks and 2 days (72 days) before the start of the study intervention (Orientation session)
- High Subjective stress defined as Perceived Stress Scale-10 score ≥ 12
- Available for the intervention sessions with reasonable certainty
- Have a device equipped with internet connection, camera and microphone and willingness to interact with study staff and class instructors virtually/remotely via this platform
- Must have a Primary Care Provider (PCP)
- Must have an accessible/active personal e-mail address or be willing to obtain one for study correspondence
Exclusion Criteria:
- Current suicidality
- History of, or meets MINI structured interview criteria for, bipolar disorder, psychosis, or other significant psychopathology; Those with depression or anxiety will be allowed to participate since they are under the care of a PCP.
- Inpatient admission for psychiatric disorder within the past two years, or ER visit for psychiatric disorder within the past 10 weeks
- Meets MINI structured interview criteria for Alcohol Use Disorder or Substance Use Disorder (Past 12 months)
- Inability to read, write or speak English
- Current enrollment in a stress reduction program, or in any other investigative study
- Previous participation in a mindfulness-based stress reduction (MBSR) course
- Pregnant women
- Have a household member who is currently, or was previously, assigned to study treatment
Sites / Locations
- Penn State College of Medicine, Penn State Milton S Hershey Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Mindfulness Based Stress Reduction
Stress Management Education
Arm Description
Outcomes
Primary Outcome Measures
Change in Hemoglobin A1c from Baseline to 6 months
Hemoglobin A1c (HbA1c) is a measure of average glucose levels over the past 3 months.
Secondary Outcome Measures
Change in Hemoglobin A1c from Baseline to 2 months
Hemoglobin A1c (HbA1c) is a measure of average glucose levels over the past 3 months.
Change in Diabetes Distress Scale from Baseline to 2 months
The Diabetes Distress Scale (DDS) is a 17-item questionnaire that assesses diabetes-related distress on a scale of 1 to 6, where 1 = Not a Problem to 6 = A Very Serious Problem. The lowest possible score is 17 and the highest possible score is 102, indicating living with diabetes is a very serious problem.
Change in Diabetes Distress Scale from Baseline to 6 months
The Diabetes Distress Scale (DDS) is a 17-item questionnaire that assesses diabetes-related distress on a scale of 1 to 6, where 1 = Not a Problem to 6 = A Very Serious Problem. The lowest possible score is 17 and the highest possible score is 102, indicating living with diabetes is a very serious problem.
Change in Perceived Stress Scale-10 from Baseline to 2 months
The Perceived Stress Scale-10 (PSS-10) is a 10-item questionnaire that assesses subjective stress on a scale of 0 to 4, where 0 = Never to 4 =Very Often. The lowest possible score is 0 and the highest possible score is 40, indicating high levels of subjective stress.
Change in Perceived Stress Scale-10 from Baseline to 6 months
The Perceived Stress Scale-10 (PSS-10) is a 10-item questionnaire that assesses subjective stress on a scale of 0 to 4, where 0 = Never to 4 =Very Often. The lowest possible score is 0 and the highest possible score is 40, indicating high levels of subjective stress.
Full Information
NCT ID
NCT04016415
First Posted
July 9, 2019
Last Updated
August 30, 2023
Sponsor
Milton S. Hershey Medical Center
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Penn State University, Rowan University, West Chester University of Pennsylvania, Georgetown University
1. Study Identification
Unique Protocol Identification Number
NCT04016415
Brief Title
Decreasing Stress in Diabetes
Acronym
De-Stress
Official Title
Decreasing Stress in Diabetes: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 28, 2020 (Actual)
Primary Completion Date
October 31, 2024 (Anticipated)
Study Completion Date
October 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Milton S. Hershey Medical Center
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Penn State University, Rowan University, West Chester University of Pennsylvania, Georgetown University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to conduct a randomized controlled trial (RCT) to determine the effects of an online 6-month Mindfulness-based stress reduction (MBSR) intervention compared to an active control Stress Management Education (SME) on glucose control in adults with uncontrolled type 1 or type 2 diabetes. The study will randomize 290 adults with uncontrolled diabetes to a 6-month MBSR intervention or SME control. Both MBSR and SME will be delivered online by experienced instructors in a live interactive virtual classroom using videoconferencing. Outcomes will be assessed at baseline, a follow-up phone call after Class #4, and study visits at 2-months and 6-months.
Detailed Description
Specific Aims are: 1) To conduct a randomized controlled trial to determine the effects of an online 6-month Mindfulness-Based Stress Reduction (MBSR) intervention compared to an active control Stress Management Education (SME) on glucose levels in 290 adults with uncontrolled type 1 or type 2 diabetes. Both MBSR and SME will be delivered online by experienced instructors in a live interactive virtual classroom using videoconferencing. The primary outcome will be hemoglobin A1c (HbA1c), a measure of the average glucose level over the past 3 months. We hypothesize that between the two groups, there will be a clinically significant 0.5% absolute difference in the mean change in HbA1c from baseline to 6-months. We will also look at the 2-month HbA1c, however it may be too brief a time period to fully capture the impact of MBSR. An absolute reduction in HbA1c of 0.5% would be expected to reduce the risk of any diabetes-related complication by at least 10%. Additionally, we will assess fasting glucose as a secondary outcome as it is linked with adverse health outcomes, and can be lowered with MBSR based on our pilot study; 2) To determine the effects of online MBSR compared to SME control on psychosocial, behavioral and physiological mechanisms potentially mediating the effects of MBSR and/or SME on glucose levels in adults with uncontrolled diabetes. Secondary outcomes include: diabetes-related distress, subjective stress, craving, the impact of COVID-19 on subjects' lives, subject expectancy, dietary intake, physical activity, and serum hsCRP as a marker of chronic inflammation. Adverse Childhood Experiences (ACEs) will be assessed at baseline. It is hypothesized that these measures may mediate the effects of MBSR and/or SME on glucose.
The proposed study has the potential to transform current standards of care for diabetes by using a novel long-term MBSR intervention as a powerful adjunct intervention for diabetes. MBSR could impact the clinical picture of diabetes by empowering patients with skills for strengthening their own internal resources to promote self regulation and adaptive coping and reduce stress reactivity, which are all essential for implementing healthy behaviors and are expected to lead to improved glucose control and reduced risk of diabetes complications. This proposal is relevant to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to conduct research on diabetes to improve people's health and quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Keywords
Stress, Psychological, Mindfulness, Meditation, Mind-Body Therapies, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a randomized, parallel group two-arm trial that will determine the effects of an online 6-month Mindfulness-based stress reduction (MBSR) intervention compared to Stress Management Education (SME) (active control) on glucose control in 290 patients with uncontrolled diabetes. Both MBSR and SME will be delivered online by experienced instructors in a live interactive virtual classroom using videoconferencing.
Masking
InvestigatorOutcomes Assessor
Masking Description
The PI, study coordinator, and all study personnel collecting outcomes, will be blinded from the treatment assignments. Only the MBSR and SME instructors and the study personnel who schedule the classes, videorecord the classes, and code the videos will have knowledge of the assignments, and these individuals will not be involved in the collection of outcomes. Subjects will be asked to keep their treatment assignment concealed from study personnel collecting outcomes. However, complete blinding may not be possible given the nature of this study.
Allocation
Randomized
Enrollment
290 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Mindfulness Based Stress Reduction
Arm Type
Experimental
Arm Title
Stress Management Education
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness Based Stress Reduction
Intervention Description
Subjects randomized to Mindfulness-Based Stress Reduction (MBSR) will receive the 8-week University of Massachusetts Authorized MBSR curriculum followed by monthly mindfulness boosters in Months 3 to 6. The University of Massachusetts MBSR curriculum was selected for the intervention, as it is the most standardized and researched mindfulness program that has been shown to reduce psychological distress in various patient populations.
Intervention Type
Behavioral
Intervention Name(s)
Stress Management Education
Intervention Description
Subjects randomized to Stress Management Education (SME) will receive health education on nutrition (adapted for the type 2 diabetes population), exercise as gentle stretching to match yoga in MBSR, and other general health topics that may be relevant to the type 2 diabetes population such as sleep, time management, etc. Stress Management Education does not have any mindfulness in it. Stress Management Education was specifically created as a control condition for MBSR studies so it matches MBSR for time, social support, homework, etc.
Primary Outcome Measure Information:
Title
Change in Hemoglobin A1c from Baseline to 6 months
Description
Hemoglobin A1c (HbA1c) is a measure of average glucose levels over the past 3 months.
Time Frame
baseline and 6 months
Secondary Outcome Measure Information:
Title
Change in Hemoglobin A1c from Baseline to 2 months
Description
Hemoglobin A1c (HbA1c) is a measure of average glucose levels over the past 3 months.
Time Frame
baseline and 2 months
Title
Change in Diabetes Distress Scale from Baseline to 2 months
Description
The Diabetes Distress Scale (DDS) is a 17-item questionnaire that assesses diabetes-related distress on a scale of 1 to 6, where 1 = Not a Problem to 6 = A Very Serious Problem. The lowest possible score is 17 and the highest possible score is 102, indicating living with diabetes is a very serious problem.
Time Frame
baseline and 2 months
Title
Change in Diabetes Distress Scale from Baseline to 6 months
Description
The Diabetes Distress Scale (DDS) is a 17-item questionnaire that assesses diabetes-related distress on a scale of 1 to 6, where 1 = Not a Problem to 6 = A Very Serious Problem. The lowest possible score is 17 and the highest possible score is 102, indicating living with diabetes is a very serious problem.
Time Frame
baseline and 6 months
Title
Change in Perceived Stress Scale-10 from Baseline to 2 months
Description
The Perceived Stress Scale-10 (PSS-10) is a 10-item questionnaire that assesses subjective stress on a scale of 0 to 4, where 0 = Never to 4 =Very Often. The lowest possible score is 0 and the highest possible score is 40, indicating high levels of subjective stress.
Time Frame
baseline and 2 months
Title
Change in Perceived Stress Scale-10 from Baseline to 6 months
Description
The Perceived Stress Scale-10 (PSS-10) is a 10-item questionnaire that assesses subjective stress on a scale of 0 to 4, where 0 = Never to 4 =Very Often. The lowest possible score is 0 and the highest possible score is 40, indicating high levels of subjective stress.
Time Frame
baseline and 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Men and Women
Age 18 years or older
Diagnosed with diabetes for at least one year
Hemoglobin A1c ≥ 7.5% within 10 weeks and 2 days (72 days) before the start of the study intervention (Orientation session)
High Subjective stress defined as Perceived Stress Scale-10 score ≥ 12
Available for the intervention sessions with reasonable certainty
Have a device equipped with internet connection, camera and microphone and willingness to interact with study staff and class instructors virtually/remotely via this platform
Must have a Primary Care Provider (PCP)
Must have an accessible/active personal e-mail address or be willing to obtain one for study correspondence
Exclusion Criteria:
Current suicidality
History of, or meets MINI structured interview criteria for, bipolar disorder, psychosis, or other significant psychopathology; Those with depression or anxiety will be allowed to participate since they are under the care of a PCP.
Inpatient admission for psychiatric disorder within the past two years, or ER visit for psychiatric disorder within the past 10 weeks
Meets MINI structured interview criteria for Alcohol Use Disorder or Substance Use Disorder (Past 12 months)
Inability to read, write or speak English
Current enrollment in a stress reduction program, or in any other investigative study
Previous participation in a mindfulness-based stress reduction (MBSR) course
Pregnant women
Have a household member who is currently, or was previously, assigned to study treatment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sundal Ghori or John Graybeal
Phone
717-531-8395
Email
dstudy@pennstatehealth.psu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nazia T Raja-Khan, M.D., M.S.
Organizational Affiliation
Milton S. Hershey Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Penn State College of Medicine, Penn State Milton S Hershey Medical Center
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sundal Ghori or John Graybeal
Phone
717-531-8395
Email
dstudy@pennstatehealth.psu.edu
First Name & Middle Initial & Last Name & Degree
Nazia T Raja-Khan, M.D., M.S.
Phone
717-531-8395
Email
nrajakhan@pennstatehealth.psu.edu
First Name & Middle Initial & Last Name & Degree
Nazia T Raja-Khan, M.D., M.S.
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The investigators will make available a complete, cleaned, de-identified copy of the final data set used in conducting the final analyses.
IPD Sharing Time Frame
Within 1 year after collecting the final outcome measure
IPD Sharing Access Criteria
If requested, the data set will be made available via the Inter-university Consortium for Political and Social Research (ICPSR), of which Pennsylvania State University is a member. Approximately 740 universities, government agencies, and other institutions are members of ICPSR. Names and other personal health identifiers (e.g., zip codes) will be withheld, so that it is not possible for individuals to be individually identified. All other data, including all adherence, outcome and covariate data will be shared in a dataset uploaded into the ICPSR repository. These data would then be shared with all investigators working under an institution with a Federal Wide Assurance (FWA) and could be used for secondary study purposes.
IPD Sharing URL
https://www.icpsr.umich.edu/web/pages/
Learn more about this trial
Decreasing Stress in Diabetes
We'll reach out to this number within 24 hrs